NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.0021
0.00 (0.00%)
Aug 31, 2026, 9:52 AM EST
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $274.27 thousand as of August 31, 2026. Its market cap has decreased by -97.23% in one year.
Market Cap
274.27K
Enterprise Value
38.46M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since August 4, 2023, NKGen Biotech's market cap has decreased from 338.09M to 274.27K, a decrease of -99.92%. That is a compound annual growth rate of -90.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 274.27K | -95.59% |
| Dec 31, 2025 | 6.22M | -73.65% |
| Dec 31, 2024 | 23.60M | -60.80% |
| Dec 29, 2023 | 60.19M | -82.20% |
| Aug 4, 2023 | 338.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| inTerra Resources | 410.75K |
| Altamira Therapeutics | 400.08K |
| Helix BioMedix | 393.24K |
| Actavia Life Sciences | 385.91K |
| Lyra Therapeutics | 354.98K |
| Regen BioPharma | 335.06K |
| Ocean Biomedical | 325.31K |
| Sorrento Therapeutics | 271.86K |